Innoviva Specialty Therapeutics, Inc.
VP, Finance
Innoviva Specialty Therapeutics, Inc., Waltham, Massachusetts, United States, 02254
Join to apply for the
VP, Finance
role at
Innoviva Specialty Therapeutics, Inc. Join to apply for the
VP, Finance
role at
Innoviva Specialty Therapeutics, Inc. Company Overview:
Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc., is a biopharmaceutical company focused on developing innovative solutions for patients and healthcare providers in the fields of Critical Care and Infectious Diseases. Company Overview:
Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc., is a biopharmaceutical company focused on developing innovative solutions for patients and healthcare providers in the fields of Critical Care and Infectious Diseases.
Our mission to deliver innovative, life-saving medicines for serious unmet medical conditions drives us every day and contributes to building a sustainable business for the long term. It also inspires our entrepreneurial culture which fosters innovation, collaboration, and a relentless commitment to the people we serve. Patients are at the center of everything we do because everyday matters. Every employee is encouraged to take initiative, explore new ideas, and turn challenges into opportunities that can potentially transform lives, especially those suffering from serious and difficult-to-treat illnesses.
Our products marketed in the U.S. include:
GIAPREZA (angiotensin II) is a vasoconstrictor to increase blood pressure in adults with septic or other distributive shock. XACDURO (sulbactam for injection; durlobactam for injection) is a new treatment designed specifically to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii-calcoaceticus complex in adults. XERAVA (eravacycline) is a broad-spectrum antibiotic used to treat patients with complicated intra-abdominal infections (cIAI). ZEVTERA (ceftobiprole) is a newly approved advanced-generation cephalosporin antibiotic and the only FDA-approved cephalosporin specifically designed to treat adult patients with Staphylococcus aureus bloodstream infections (bacteremia) including those with right-sided infective endocarditis. In addition, Zevtera is approved in adult patients with acute bacterial skin and skin structure infections (ABSSSI), and adult and pediatric patients (3 months to less than 18 years old) with community-acquired bacterial pneumonia (CABP).
Summary of Position
:
The Vice President of Finance is responsible for leading and driving all aspects of Financial Planning & Analysis (FP&A) at Innoviva Specialty Therapeutics. In this role, you will be shaping and executing a best-in-class financial strategy that supports the company's ambitious growth trajectory and long-term value creation. This role is instrumental in building scalable financial systems and processes, supporting operational excellence, and advancing the company’s mission through impactful financial leadership. The VP will lead and inspire a high-performing FP&A team, fostering a culture of collaboration, accountability, and continuous improvement.
Reporting directly to the CFO/Interim President, the VP serves as a key strategic partner to the executive leadership team, driving forward-looking financial insights, enabling data-driven decisions, and ensuring strong fiscal stewardship across the organization. The role plays a critical function in translating business objectives into clear financial plans, forecasts, and performance metrics.
Responsibilities
:
Lead the FP&A function, establishing the vision, frameworks, and processes for accurate forecasting, budgeting, and long-range planning aligned with corporate goals. Serve as the senior leader of FP&A, transforming the function into a proactive, strategic partner to the business. Provide financial insight and decision support to the executive team, directly influencing growth strategies and resource allocation. Partner cross-functionally with internal stakeholders to evaluate business opportunities, risks, and trade-offs. Drive long-range financial planning and scenario modeling to support innovation and growth. Deliver timely, accurate, and actionable financial reports, KPIs, and dashboards to enable operational excellence. Analyze business performance to identify trends, optimize profitability, and improve efficiency. Continuously enhance FP&A tools, data integrity, and processes to enable real-time, fact-based decision-making. Build and maintain strong relationships across the organization, modeling values-based leadership and fostering a unified sense of purpose. Ensure all FP&A activities adhere to corporate policies, GAAP, and applicable regulatory standards. Collaborate closely with accounting and other finance leaders to align corporate financial strategy and reporting. Attract, develop, and inspire a high-performing FP&A team within a culture of growth, accountability, and innovation.
Experience & Education:
MBA or advanced degree in Finance, Accounting, or a related field ( CPA or CFA preferred) 15 plus years of progressive finance experience, including at least 10 years in senior FP&A leadership roles Proven success in public company environments, with experience navigating investor expectations and regulatory requirements Experience with commercial pharmaceutical or biotech settings Track record of building and leading high-performing teams and driving cultural excellence Deep experience partnering with C-suite executives to influence business strategy and optimize financial performance Expertise in financial modeling, forecasting, budgeting, scenario analysis, and performance measurement
Skills and Abilities:
Strong strategic thinking and business acumen Excellent communication and influencing skills with the ability to present to executive leaders Ability to thrive in a fast-paced, evolving environment with competing priorities Executive presence with demonstrated experience leading cross-functional collaboration Passion for driving business impact and building a finance organization that serves as a true strategic partner
The above statements are intended to describe the general nature and level of work being performed by employees assigned to this classification. They are not intended to be construed as an exhaustive list of all responsibilities, duties and skills required of employees assigned to this position.
Innoviva Specialty Therapeutics is an equal opportunity employer that is committed to diversity and inclusion in the workplace. We prohibit discrimination and harassment of any kind based on race, color, sex, religion, sexual orientation, national origin, disability, genetic information, pregnancy, or any other protected characteristic as outlined by federal, state, or local laws. Seniority level
Seniority level Executive Employment type
Employment type Full-time Job function
Job function Finance and Sales Referrals increase your chances of interviewing at Innoviva Specialty Therapeutics, Inc. by 2x Sign in to set job alerts for “Vice President Finance” roles.
Accounting Manager/ Senior Accounting Manager
Waltham, MA $150,000.00-$190,000.00 3 days ago Senior Director of Accounting, Corporate Controller
Waltham, MA $120,000.00-$130,000.00 3 days ago Reading, MA $140,000.00-$180,000.00 2 days ago Danvers, MA $155,000.00-$200,000.00 2 weeks ago Waltham, MA $120,000.00-$130,000.00 1 day ago Boston, MA $110,000.00-$130,000.00 2 weeks ago Remote - Senior Director, Fund Accounting ($220K Base + Bonus) - 27446
Boston, MA $250,000.00-$300,000.00 2 weeks ago Concord, MA $120,000.00-$140,000.00 3 weeks ago Greater Boston $125,000.00-$160,000.00 4 days ago We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
#J-18808-Ljbffr
VP, Finance
role at
Innoviva Specialty Therapeutics, Inc. Join to apply for the
VP, Finance
role at
Innoviva Specialty Therapeutics, Inc. Company Overview:
Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc., is a biopharmaceutical company focused on developing innovative solutions for patients and healthcare providers in the fields of Critical Care and Infectious Diseases. Company Overview:
Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc., is a biopharmaceutical company focused on developing innovative solutions for patients and healthcare providers in the fields of Critical Care and Infectious Diseases.
Our mission to deliver innovative, life-saving medicines for serious unmet medical conditions drives us every day and contributes to building a sustainable business for the long term. It also inspires our entrepreneurial culture which fosters innovation, collaboration, and a relentless commitment to the people we serve. Patients are at the center of everything we do because everyday matters. Every employee is encouraged to take initiative, explore new ideas, and turn challenges into opportunities that can potentially transform lives, especially those suffering from serious and difficult-to-treat illnesses.
Our products marketed in the U.S. include:
GIAPREZA (angiotensin II) is a vasoconstrictor to increase blood pressure in adults with septic or other distributive shock. XACDURO (sulbactam for injection; durlobactam for injection) is a new treatment designed specifically to treat hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii-calcoaceticus complex in adults. XERAVA (eravacycline) is a broad-spectrum antibiotic used to treat patients with complicated intra-abdominal infections (cIAI). ZEVTERA (ceftobiprole) is a newly approved advanced-generation cephalosporin antibiotic and the only FDA-approved cephalosporin specifically designed to treat adult patients with Staphylococcus aureus bloodstream infections (bacteremia) including those with right-sided infective endocarditis. In addition, Zevtera is approved in adult patients with acute bacterial skin and skin structure infections (ABSSSI), and adult and pediatric patients (3 months to less than 18 years old) with community-acquired bacterial pneumonia (CABP).
Summary of Position
:
The Vice President of Finance is responsible for leading and driving all aspects of Financial Planning & Analysis (FP&A) at Innoviva Specialty Therapeutics. In this role, you will be shaping and executing a best-in-class financial strategy that supports the company's ambitious growth trajectory and long-term value creation. This role is instrumental in building scalable financial systems and processes, supporting operational excellence, and advancing the company’s mission through impactful financial leadership. The VP will lead and inspire a high-performing FP&A team, fostering a culture of collaboration, accountability, and continuous improvement.
Reporting directly to the CFO/Interim President, the VP serves as a key strategic partner to the executive leadership team, driving forward-looking financial insights, enabling data-driven decisions, and ensuring strong fiscal stewardship across the organization. The role plays a critical function in translating business objectives into clear financial plans, forecasts, and performance metrics.
Responsibilities
:
Lead the FP&A function, establishing the vision, frameworks, and processes for accurate forecasting, budgeting, and long-range planning aligned with corporate goals. Serve as the senior leader of FP&A, transforming the function into a proactive, strategic partner to the business. Provide financial insight and decision support to the executive team, directly influencing growth strategies and resource allocation. Partner cross-functionally with internal stakeholders to evaluate business opportunities, risks, and trade-offs. Drive long-range financial planning and scenario modeling to support innovation and growth. Deliver timely, accurate, and actionable financial reports, KPIs, and dashboards to enable operational excellence. Analyze business performance to identify trends, optimize profitability, and improve efficiency. Continuously enhance FP&A tools, data integrity, and processes to enable real-time, fact-based decision-making. Build and maintain strong relationships across the organization, modeling values-based leadership and fostering a unified sense of purpose. Ensure all FP&A activities adhere to corporate policies, GAAP, and applicable regulatory standards. Collaborate closely with accounting and other finance leaders to align corporate financial strategy and reporting. Attract, develop, and inspire a high-performing FP&A team within a culture of growth, accountability, and innovation.
Experience & Education:
MBA or advanced degree in Finance, Accounting, or a related field ( CPA or CFA preferred) 15 plus years of progressive finance experience, including at least 10 years in senior FP&A leadership roles Proven success in public company environments, with experience navigating investor expectations and regulatory requirements Experience with commercial pharmaceutical or biotech settings Track record of building and leading high-performing teams and driving cultural excellence Deep experience partnering with C-suite executives to influence business strategy and optimize financial performance Expertise in financial modeling, forecasting, budgeting, scenario analysis, and performance measurement
Skills and Abilities:
Strong strategic thinking and business acumen Excellent communication and influencing skills with the ability to present to executive leaders Ability to thrive in a fast-paced, evolving environment with competing priorities Executive presence with demonstrated experience leading cross-functional collaboration Passion for driving business impact and building a finance organization that serves as a true strategic partner
The above statements are intended to describe the general nature and level of work being performed by employees assigned to this classification. They are not intended to be construed as an exhaustive list of all responsibilities, duties and skills required of employees assigned to this position.
Innoviva Specialty Therapeutics is an equal opportunity employer that is committed to diversity and inclusion in the workplace. We prohibit discrimination and harassment of any kind based on race, color, sex, religion, sexual orientation, national origin, disability, genetic information, pregnancy, or any other protected characteristic as outlined by federal, state, or local laws. Seniority level
Seniority level Executive Employment type
Employment type Full-time Job function
Job function Finance and Sales Referrals increase your chances of interviewing at Innoviva Specialty Therapeutics, Inc. by 2x Sign in to set job alerts for “Vice President Finance” roles.
Accounting Manager/ Senior Accounting Manager
Waltham, MA $150,000.00-$190,000.00 3 days ago Senior Director of Accounting, Corporate Controller
Waltham, MA $120,000.00-$130,000.00 3 days ago Reading, MA $140,000.00-$180,000.00 2 days ago Danvers, MA $155,000.00-$200,000.00 2 weeks ago Waltham, MA $120,000.00-$130,000.00 1 day ago Boston, MA $110,000.00-$130,000.00 2 weeks ago Remote - Senior Director, Fund Accounting ($220K Base + Bonus) - 27446
Boston, MA $250,000.00-$300,000.00 2 weeks ago Concord, MA $120,000.00-$140,000.00 3 weeks ago Greater Boston $125,000.00-$160,000.00 4 days ago We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
#J-18808-Ljbffr